Nucleix vs OutSense Diagnostics
Nucleix vs OutSense Diagnostics, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Nucleix is on 56/100 and OutSense Diagnostics on 51/100.
Where each one leads
Nucleix
- our overall score: 56/100 against 51/100
- headcount: 74 against 23
- funding raised: $88.0M against $2.7M
- LinkedIn following: 7,846 against 1,343
OutSense Diagnostics
- domain rating: 44/100 against 38/100
At a glance
| Measure | Nucleix | OutSense Diagnostics |
|---|---|---|
| What it is | Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis. | Develops toilet-integrated diagnostic technology for early health condition detection. |
| Category | Healthcare, Lung, Bladder, Cancer | Healthcare, Personal, Toilet, Detection |
| Sells toBusiness model | B2B | B2B, B2C |
| Offering | Software | Hardware, Software |
| Founded | 2008 | 2016 |
| Headquarters | Rehovot, Israel | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | Nucleix | OutSense Diagnostics |
|---|---|---|
| Employees | 74 | 23 |
| Headcount growthLast 12 months | +7.1% | Not published |
| Total funding | $88.0M | $2.7M |
| Latest round | Funding Round | Series A |
| LinkedIn followers | 7,846 | 1,343 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Nucleix | OutSense Diagnostics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 56/100 | 51/100 |
| Traction | 59/100 | 46/100 |
| Team | 70/100 | 60/100 |
| Search visibility | 36/100 | 30/100 |
| Quality | 55/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (30/100) | F (29/100) |
| Domain ratingLink authority, 0-100 | 38/100 | 44/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Nucleix | OutSense Diagnostics |
|---|---|---|
| CDN | Cloudflare | Cloudflare |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Next.js, Tailwind CSS |
| Analytics | Google Analytics 4 | Not detected |
What users say
| Measure | Nucleix | OutSense Diagnostics |
|---|---|---|
| Reddit sentimentThreads we track | 6 positive, 0 negative across 6 threads | Not published |
“Nucleix Demonstrates Potential of its PCR EpiCheck® Assay to Accurately Differentiate Between Small Cell Lung Cancer (SCLC) Subtypes.”r/LungCancerSupport
Nucleix vs OutSense Diagnostics: common questions
Which is better, Nucleix or OutSense Diagnostics?
On our 0-100 score Nucleix rates higher (56/100 against 51/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Nucleix and OutSense Diagnostics compare on the numbers?
Nucleix leads on our overall score (56/100 against 51/100), headcount (74 against 23), funding raised ($88.0M against $2.7M), LinkedIn following (7,846 against 1,343). OutSense Diagnostics leads on domain rating (44/100 against 38/100).
What do real users say about Nucleix and OutSense Diagnostics?
Nucleix: 6 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/LungCancerSupport.
Read the full Nucleix review and pricing or the OutSense Diagnostics review and pricing. You can also browse other Nucleix alternatives we track.